secwatch.observer — SEC 8-K summary
======================================

Issuer:     Journey Medical Corp (DERM)
CIK:        0001867066
Form:       8-K
Filed at:   2022-07-22T23:59:59+00:00
Accession:  0001104659-22-081994
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Journey Medical grants 300k RSUs to CEO, 150k RSUs to CFO
---------------------------------------------------------

- CEO Claude Maraoui received 300,000 RSUs; CFO Ernest De Paolantonio received 150,000 RSUs.
- RSUs vest in four equal annual installments beginning on July 21, 2023.
- Grants approved by Board on July 21, 2022 under the 2015 Stock Plan.
- Unvested RSUs subject to forfeiture upon termination; full vesting upon Change of Control.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1867066/000110465922081994/0001104659-22-081994-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1867066/000110465922081994/tm2221474d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-081994

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer